Cheryl Ackert-Bicknell
Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteoporosis | 15 | 2024 | 232 | 3.620 |
Why?
| Bone Density | 30 | 2023 | 471 | 3.090 |
Why?
| Bone and Bones | 14 | 2023 | 298 | 2.030 |
Why?
| Quantitative Trait Loci | 19 | 2022 | 355 | 1.860 |
Why?
| Genome-Wide Association Study | 20 | 2023 | 1332 | 1.740 |
Why?
| Osteoblasts | 14 | 2021 | 124 | 1.150 |
Why?
| Zebrafish | 5 | 2024 | 458 | 1.040 |
Why?
| Genetic Variation | 8 | 2019 | 937 | 0.900 |
Why?
| Femur | 10 | 2018 | 244 | 0.860 |
Why?
| Chromosome Mapping | 10 | 2019 | 504 | 0.820 |
Why?
| Musculoskeletal Diseases | 2 | 2024 | 69 | 0.820 |
Why?
| Mice | 55 | 2024 | 16861 | 0.820 |
Why?
| Intervertebral Disc Degeneration | 1 | 2023 | 33 | 0.800 |
Why?
| Intervertebral Disc | 1 | 2023 | 39 | 0.800 |
Why?
| Intervertebral Disc Displacement | 1 | 2023 | 39 | 0.800 |
Why?
| Animals | 66 | 2024 | 35219 | 0.690 |
Why?
| Osteoporotic Fractures | 2 | 2022 | 57 | 0.650 |
Why?
| Spine | 2 | 2018 | 158 | 0.640 |
Why?
| Genome | 3 | 2019 | 277 | 0.630 |
Why?
| Insulin-Like Growth Factor I | 9 | 2008 | 307 | 0.610 |
Why?
| Fracture Healing | 2 | 2016 | 75 | 0.610 |
Why?
| Fractures, Bone | 4 | 2022 | 392 | 0.600 |
Why?
| Mice, Inbred C57BL | 16 | 2020 | 5408 | 0.540 |
Why?
| Skeleton | 1 | 2016 | 5 | 0.530 |
Why?
| Polymorphism, Single Nucleotide | 17 | 2021 | 2071 | 0.520 |
Why?
| Alternative Splicing | 1 | 2018 | 218 | 0.510 |
Why?
| Phenotype | 19 | 2024 | 3074 | 0.510 |
Why?
| PPAR gamma | 5 | 2010 | 183 | 0.510 |
Why?
| Diphosphonates | 1 | 2016 | 56 | 0.490 |
Why?
| Laboratory Animal Science | 1 | 2015 | 4 | 0.490 |
Why?
| Bone Density Conservation Agents | 1 | 2016 | 70 | 0.480 |
Why?
| Gene-Environment Interaction | 2 | 2013 | 185 | 0.470 |
Why?
| Disease Models, Animal | 8 | 2024 | 4049 | 0.420 |
Why?
| Lipoproteins, HDL | 2 | 2013 | 85 | 0.420 |
Why?
| Body Composition | 6 | 2010 | 649 | 0.400 |
Why?
| Aging | 5 | 2021 | 1774 | 0.390 |
Why?
| GATA Transcription Factors | 1 | 2012 | 7 | 0.390 |
Why?
| Hip | 1 | 2012 | 55 | 0.370 |
Why?
| Cholesterol, HDL | 1 | 2012 | 205 | 0.360 |
Why?
| Mice, Inbred Strains | 9 | 2015 | 406 | 0.360 |
Why?
| Mice, Inbred C3H | 9 | 2010 | 273 | 0.350 |
Why?
| Genetic Predisposition to Disease | 7 | 2022 | 2281 | 0.350 |
Why?
| Thiazolidinediones | 2 | 2008 | 137 | 0.350 |
Why?
| Chromosome Inversion | 2 | 2007 | 17 | 0.340 |
Why?
| Transcription Factors | 4 | 2023 | 1649 | 0.340 |
Why?
| DNA-Binding Proteins | 3 | 2020 | 1443 | 0.340 |
Why?
| Dietary Fats | 2 | 2011 | 301 | 0.340 |
Why?
| Gene Regulatory Networks | 3 | 2021 | 284 | 0.340 |
Why?
| Crosses, Genetic | 6 | 2012 | 142 | 0.320 |
Why?
| Carrier Proteins | 5 | 2017 | 740 | 0.300 |
Why?
| Gene Expression Regulation | 9 | 2020 | 2543 | 0.290 |
Why?
| Genetic Association Studies | 3 | 2016 | 360 | 0.280 |
Why?
| Osteogenesis | 4 | 2021 | 175 | 0.280 |
Why?
| Chromosomes, Mammalian | 4 | 2012 | 26 | 0.270 |
Why?
| Cell Differentiation | 6 | 2021 | 1899 | 0.270 |
Why?
| Humans | 38 | 2024 | 129219 | 0.260 |
Why?
| CRISPR-Cas Systems | 2 | 2024 | 109 | 0.250 |
Why?
| Mice, Knockout | 9 | 2020 | 2856 | 0.250 |
Why?
| Genetic Pleiotropy | 2 | 2017 | 29 | 0.230 |
Why?
| Pseudarthrosis | 1 | 2024 | 11 | 0.230 |
Why?
| Diskectomy | 1 | 2024 | 21 | 0.230 |
Why?
| Meta-Analysis as Topic | 2 | 2017 | 169 | 0.230 |
Why?
| Lipoproteins, LDL | 1 | 2024 | 127 | 0.220 |
Why?
| Bone Diseases | 2 | 2015 | 57 | 0.220 |
Why?
| Calcification, Physiologic | 2 | 2021 | 34 | 0.220 |
Why?
| Adipose Tissue | 2 | 2007 | 590 | 0.220 |
Why?
| Longevity | 2 | 2015 | 150 | 0.220 |
Why?
| X-Ray Microtomography | 4 | 2018 | 84 | 0.220 |
Why?
| Allelic Imbalance | 1 | 2023 | 8 | 0.220 |
Why?
| Sarcopenia | 2 | 2024 | 74 | 0.210 |
Why?
| Cervical Vertebrae | 1 | 2024 | 132 | 0.210 |
Why?
| Craniosynostoses | 1 | 2023 | 35 | 0.210 |
Why?
| Organ Size | 4 | 2017 | 445 | 0.200 |
Why?
| Femoracetabular Impingement | 1 | 2022 | 34 | 0.200 |
Why?
| Osteoarthritis, Hip | 1 | 2022 | 43 | 0.200 |
Why?
| Behavior, Animal | 2 | 2016 | 506 | 0.190 |
Why?
| Exons | 2 | 2018 | 342 | 0.190 |
Why?
| HMGB1 Protein | 1 | 2022 | 48 | 0.190 |
Why?
| Biology | 1 | 2023 | 83 | 0.190 |
Why?
| Skull | 3 | 2023 | 129 | 0.190 |
Why?
| Cell Culture Techniques | 2 | 2022 | 345 | 0.190 |
Why?
| Zebrafish Proteins | 1 | 2024 | 265 | 0.190 |
Why?
| Mammals | 1 | 2023 | 269 | 0.190 |
Why?
| Regenerative Medicine | 1 | 2022 | 46 | 0.190 |
Why?
| Spinal Fusion | 1 | 2024 | 230 | 0.190 |
Why?
| Musculoskeletal System | 1 | 2022 | 45 | 0.190 |
Why?
| Erythropoietin | 1 | 2022 | 86 | 0.180 |
Why?
| Genotype | 5 | 2018 | 1839 | 0.180 |
Why?
| Bone Marrow | 2 | 2015 | 270 | 0.180 |
Why?
| Anemia | 1 | 2022 | 160 | 0.180 |
Why?
| Antibody-Producing Cells | 1 | 2020 | 30 | 0.170 |
Why?
| Muscle Weakness | 1 | 2021 | 84 | 0.170 |
Why?
| Male | 27 | 2024 | 63498 | 0.170 |
Why?
| Female | 34 | 2024 | 68607 | 0.170 |
Why?
| Computational Biology | 2 | 2021 | 597 | 0.170 |
Why?
| Adipogenesis | 2 | 2010 | 50 | 0.170 |
Why?
| Cell Separation | 1 | 2021 | 316 | 0.160 |
Why?
| Antibodies, Bacterial | 1 | 2020 | 137 | 0.160 |
Why?
| Tetraspanins | 1 | 2019 | 19 | 0.160 |
Why?
| Cartilage, Articular | 1 | 2022 | 292 | 0.160 |
Why?
| Promoter Regions, Genetic | 2 | 2018 | 1206 | 0.150 |
Why?
| Untranslated Regions | 1 | 2018 | 3 | 0.150 |
Why?
| Sex Characteristics | 2 | 2018 | 732 | 0.150 |
Why?
| RAW 264.7 Cells | 1 | 2018 | 49 | 0.150 |
Why?
| Osteomyelitis | 1 | 2020 | 122 | 0.150 |
Why?
| Transcriptome | 5 | 2022 | 885 | 0.150 |
Why?
| Information Management | 1 | 2018 | 15 | 0.150 |
Why?
| Musculoskeletal Development | 1 | 2017 | 2 | 0.140 |
Why?
| Cell Line | 5 | 2018 | 2777 | 0.140 |
Why?
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 57 | 0.140 |
Why?
| Genetic Markers | 2 | 2016 | 338 | 0.140 |
Why?
| Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2017 | 7 | 0.140 |
Why?
| Quantitative Trait, Heritable | 2 | 2018 | 120 | 0.140 |
Why?
| Calcaneus | 1 | 2017 | 31 | 0.140 |
Why?
| Oncogene Proteins, Fusion | 1 | 2019 | 201 | 0.140 |
Why?
| Nuclear Proteins | 3 | 2011 | 663 | 0.140 |
Why?
| Excitatory Amino Acid Transporter 1 | 1 | 2016 | 5 | 0.130 |
Why?
| Species Specificity | 5 | 2014 | 574 | 0.130 |
Why?
| Receptor, EphB2 | 1 | 2016 | 4 | 0.130 |
Why?
| Wnt Proteins | 2 | 2015 | 127 | 0.130 |
Why?
| Animals, Outbred Strains | 1 | 2016 | 4 | 0.130 |
Why?
| Leukocytes | 1 | 2018 | 303 | 0.130 |
Why?
| Glycoproteins | 3 | 2003 | 338 | 0.130 |
Why?
| Retinal Vessels | 1 | 2017 | 65 | 0.130 |
Why?
| Histological Techniques | 1 | 2016 | 40 | 0.130 |
Why?
| Minerals | 1 | 2016 | 41 | 0.130 |
Why?
| Mutagenesis | 1 | 2017 | 181 | 0.130 |
Why?
| Pelvic Bones | 1 | 2019 | 156 | 0.130 |
Why?
| Staphylococcus aureus | 1 | 2020 | 436 | 0.130 |
Why?
| Sepsis | 1 | 2022 | 571 | 0.130 |
Why?
| Databases, Genetic | 2 | 2014 | 232 | 0.130 |
Why?
| Osteoarthritis | 1 | 2018 | 166 | 0.130 |
Why?
| Immunoglobulin G | 1 | 2020 | 845 | 0.130 |
Why?
| Program Development | 1 | 2018 | 356 | 0.120 |
Why?
| Stem Cells | 2 | 2022 | 577 | 0.120 |
Why?
| Rodent Diseases | 1 | 2015 | 28 | 0.120 |
Why?
| Animal Structures | 1 | 2015 | 9 | 0.120 |
Why?
| Staphylococcal Infections | 1 | 2020 | 392 | 0.120 |
Why?
| Spinal Fractures | 1 | 2016 | 81 | 0.120 |
Why?
| Bone Resorption | 1 | 2016 | 79 | 0.120 |
Why?
| Haplotypes | 3 | 2012 | 475 | 0.120 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2021 | 820 | 0.120 |
Why?
| Gene Expression Profiling | 4 | 2017 | 1705 | 0.110 |
Why?
| Linkage Disequilibrium | 3 | 2021 | 257 | 0.110 |
Why?
| Fracture Fixation, Intramedullary | 1 | 2015 | 60 | 0.110 |
Why?
| Rats | 1 | 2023 | 5462 | 0.110 |
Why?
| Face | 1 | 2015 | 165 | 0.110 |
Why?
| Guanine Nucleotide Exchange Factors | 1 | 2014 | 63 | 0.110 |
Why?
| Urination | 1 | 2014 | 44 | 0.110 |
Why?
| Urodynamics | 1 | 2014 | 35 | 0.110 |
Why?
| Mice, Transgenic | 3 | 2015 | 2111 | 0.110 |
Why?
| Transcription, Genetic | 4 | 2020 | 1415 | 0.110 |
Why?
| Inbreeding | 2 | 2011 | 17 | 0.110 |
Why?
| Animals, Newborn | 4 | 2021 | 826 | 0.100 |
Why?
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2013 | 13 | 0.100 |
Why?
| Postoperative Complications | 1 | 2024 | 2476 | 0.100 |
Why?
| Genome, Human | 1 | 2015 | 393 | 0.100 |
Why?
| Lower Urinary Tract Symptoms | 1 | 2014 | 54 | 0.100 |
Why?
| Genomics | 3 | 2015 | 715 | 0.100 |
Why?
| Actins | 2 | 2024 | 408 | 0.100 |
Why?
| Ovariectomy | 2 | 2011 | 136 | 0.100 |
Why?
| Adipocytes | 3 | 2010 | 205 | 0.100 |
Why?
| Cohort Studies | 4 | 2024 | 5408 | 0.100 |
Why?
| Databases, Factual | 1 | 2018 | 1269 | 0.100 |
Why?
| Bone Marrow Cells | 4 | 2010 | 297 | 0.100 |
Why?
| Sequence Analysis, DNA | 3 | 2015 | 778 | 0.100 |
Why?
| RNA Editing | 1 | 2012 | 20 | 0.100 |
Why?
| Lod Score | 1 | 2012 | 66 | 0.100 |
Why?
| Stromal Cells | 4 | 2006 | 107 | 0.100 |
Why?
| Adipose Tissue, White | 1 | 2012 | 37 | 0.100 |
Why?
| Liver | 6 | 2012 | 1838 | 0.090 |
Why?
| Homeodomain Proteins | 1 | 2015 | 494 | 0.090 |
Why?
| Environment | 1 | 2013 | 342 | 0.090 |
Why?
| 3' Untranslated Regions | 1 | 2012 | 138 | 0.090 |
Why?
| Inflammation | 2 | 2022 | 2723 | 0.090 |
Why?
| Receptors, Cytoplasmic and Nuclear | 2 | 2003 | 217 | 0.090 |
Why?
| Myogenic Regulatory Factors | 1 | 2010 | 56 | 0.090 |
Why?
| MEF2 Transcription Factors | 1 | 2010 | 61 | 0.090 |
Why?
| Membrane Glycoproteins | 2 | 2003 | 473 | 0.090 |
Why?
| Gastrointestinal Microbiome | 1 | 2018 | 640 | 0.090 |
Why?
| Reproducibility of Results | 3 | 2019 | 3067 | 0.090 |
Why?
| Severity of Illness Index | 1 | 2018 | 2736 | 0.080 |
Why?
| Sequence Analysis, RNA | 2 | 2022 | 428 | 0.080 |
Why?
| Circadian Rhythm | 2 | 2010 | 412 | 0.080 |
Why?
| Estrogens | 1 | 2012 | 346 | 0.080 |
Why?
| Research Design | 1 | 2015 | 1038 | 0.080 |
Why?
| Bone Development | 2 | 2014 | 49 | 0.080 |
Why?
| Repressor Proteins | 1 | 2012 | 406 | 0.080 |
Why?
| Mice, Inbred DBA | 1 | 2008 | 188 | 0.080 |
Why?
| RNA, Messenger | 7 | 2019 | 2702 | 0.070 |
Why?
| Gene Expression | 4 | 2019 | 1469 | 0.070 |
Why?
| Alleles | 2 | 2008 | 845 | 0.070 |
Why?
| Europe | 2 | 2021 | 362 | 0.070 |
Why?
| Models, Animal | 2 | 2014 | 373 | 0.070 |
Why?
| Somatomedins | 1 | 2006 | 28 | 0.070 |
Why?
| Molecular Sequence Annotation | 2 | 2017 | 87 | 0.070 |
Why?
| Cells, Cultured | 4 | 2020 | 4072 | 0.070 |
Why?
| Muscle, Skeletal | 3 | 2024 | 1614 | 0.060 |
Why?
| Mutation | 1 | 2017 | 3715 | 0.060 |
Why?
| Bone Remodeling | 1 | 2006 | 71 | 0.060 |
Why?
| Aged | 5 | 2024 | 22030 | 0.060 |
Why?
| MicroRNAs | 1 | 2012 | 675 | 0.060 |
Why?
| Keratins | 1 | 2006 | 175 | 0.060 |
Why?
| Myogenic Regulatory Factor 5 | 1 | 2024 | 6 | 0.060 |
Why?
| Mammary Glands, Animal | 1 | 2006 | 124 | 0.060 |
Why?
| Morphogenesis | 1 | 2006 | 158 | 0.060 |
Why?
| MyoD Protein | 1 | 2024 | 32 | 0.060 |
Why?
| Fish Oils | 1 | 2024 | 26 | 0.060 |
Why?
| Obesity | 1 | 2018 | 2876 | 0.060 |
Why?
| Gene Knockout Techniques | 1 | 2024 | 109 | 0.060 |
Why?
| Muscular Diseases | 1 | 2024 | 107 | 0.060 |
Why?
| Granulosa Cell Tumor | 1 | 2003 | 6 | 0.060 |
Why?
| Muscle Development | 1 | 2024 | 103 | 0.060 |
Why?
| X Chromosome | 1 | 2003 | 52 | 0.050 |
Why?
| Larva | 1 | 2024 | 213 | 0.050 |
Why?
| Genetic Diseases, X-Linked | 1 | 2003 | 23 | 0.050 |
Why?
| Adiposity | 1 | 2008 | 504 | 0.050 |
Why?
| Transcription Initiation Site | 1 | 2023 | 43 | 0.050 |
Why?
| Lipids | 1 | 2007 | 624 | 0.050 |
Why?
| Oncogenes | 1 | 2003 | 113 | 0.050 |
Why?
| Uncertainty | 1 | 2023 | 114 | 0.050 |
Why?
| Osteoclasts | 2 | 2017 | 42 | 0.050 |
Why?
| Polymorphism, Genetic | 1 | 2005 | 640 | 0.050 |
Why?
| Receptors, Erythropoietin | 1 | 2022 | 20 | 0.050 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 958 | 0.050 |
Why?
| Erythropoiesis | 1 | 2022 | 51 | 0.050 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2024 | 398 | 0.050 |
Why?
| Body Weight | 3 | 2017 | 938 | 0.050 |
Why?
| Protein Isoforms | 1 | 2023 | 390 | 0.050 |
Why?
| Gene Ontology | 1 | 2021 | 51 | 0.050 |
Why?
| Lipid Metabolism | 1 | 2024 | 497 | 0.050 |
Why?
| Growth Differentiation Factor 5 | 1 | 2021 | 2 | 0.050 |
Why?
| Hip Joint | 1 | 2022 | 158 | 0.050 |
Why?
| Bone Matrix | 1 | 2021 | 5 | 0.050 |
Why?
| HLA-DQ alpha-Chains | 1 | 2021 | 16 | 0.050 |
Why?
| Clinical Protocols | 1 | 2022 | 254 | 0.040 |
Why?
| Gene Frequency | 2 | 2015 | 503 | 0.040 |
Why?
| Growth Hormone | 3 | 2006 | 96 | 0.040 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 428 | 0.040 |
Why?
| Wnt4 Protein | 1 | 2020 | 19 | 0.040 |
Why?
| Middle Aged | 4 | 2024 | 31075 | 0.040 |
Why?
| Hypoglycemic Agents | 1 | 2008 | 1218 | 0.040 |
Why?
| Cortical Bone | 1 | 2019 | 18 | 0.040 |
Why?
| ROC Curve | 1 | 2020 | 503 | 0.040 |
Why?
| Bifidobacterium longum | 1 | 2018 | 6 | 0.040 |
Why?
| Calcium | 1 | 2024 | 1203 | 0.040 |
Why?
| Nitric Oxide | 1 | 2003 | 899 | 0.040 |
Why?
| Ovarian Neoplasms | 1 | 2003 | 487 | 0.040 |
Why?
| Hip Fractures | 1 | 2019 | 83 | 0.040 |
Why?
| Oligosaccharides | 1 | 2018 | 57 | 0.040 |
Why?
| Muscle Strength | 1 | 2021 | 303 | 0.040 |
Why?
| Glypicans | 1 | 2017 | 9 | 0.040 |
Why?
| Tissue Engineering | 1 | 2022 | 396 | 0.040 |
Why?
| Osteochondrodysplasias | 1 | 2017 | 16 | 0.040 |
Why?
| Osteocytes | 1 | 2017 | 27 | 0.040 |
Why?
| Electroretinography | 1 | 2017 | 44 | 0.030 |
Why?
| Growth Disorders | 1 | 2017 | 80 | 0.030 |
Why?
| Adult | 4 | 2024 | 35471 | 0.030 |
Why?
| Cancellous Bone | 1 | 2016 | 21 | 0.030 |
Why?
| Homozygote | 1 | 2017 | 193 | 0.030 |
Why?
| Dysbiosis | 1 | 2018 | 167 | 0.030 |
Why?
| Genetic Loci | 1 | 2018 | 275 | 0.030 |
Why?
| RNA | 1 | 2022 | 883 | 0.030 |
Why?
| Mice, Congenic | 2 | 2006 | 22 | 0.030 |
Why?
| Polymerase Chain Reaction | 2 | 2012 | 1036 | 0.030 |
Why?
| Cryopreservation | 1 | 2016 | 97 | 0.030 |
Why?
| Age Factors | 2 | 2018 | 3137 | 0.030 |
Why?
| Wnt Signaling Pathway | 1 | 2017 | 168 | 0.030 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 768 | 0.030 |
Why?
| Base Sequence | 2 | 2012 | 2141 | 0.030 |
Why?
| Regression Analysis | 1 | 2018 | 993 | 0.030 |
Why?
| Mice, Mutant Strains | 1 | 2015 | 298 | 0.030 |
Why?
| Disease Progression | 1 | 2022 | 2622 | 0.030 |
Why?
| Mice, Inbred NZB | 2 | 2006 | 16 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2020 | 1944 | 0.030 |
Why?
| Lumbar Vertebrae | 1 | 2016 | 231 | 0.030 |
Why?
| Genes, Reporter | 1 | 2015 | 266 | 0.030 |
Why?
| Molecular Sequence Data | 2 | 2012 | 2830 | 0.030 |
Why?
| Exome | 1 | 2015 | 220 | 0.030 |
Why?
| Epigenesis, Genetic | 1 | 2019 | 613 | 0.030 |
Why?
| Tibial Fractures | 1 | 2015 | 72 | 0.030 |
Why?
| Insulin-Like Growth Factor Binding Proteins | 2 | 2004 | 29 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2017 | 1500 | 0.030 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 2 | 2003 | 8 | 0.030 |
Why?
| Upper Extremity | 1 | 2014 | 92 | 0.030 |
Why?
| RANK Ligand | 2 | 2003 | 26 | 0.030 |
Why?
| Osteoprotegerin | 2 | 2003 | 24 | 0.030 |
Why?
| Fibrosis | 1 | 2015 | 520 | 0.030 |
Why?
| Biopsy | 1 | 2016 | 1087 | 0.030 |
Why?
| Case-Control Studies | 1 | 2020 | 3372 | 0.030 |
Why?
| Child | 3 | 2018 | 20853 | 0.020 |
Why?
| Receptors, Tumor Necrosis Factor | 2 | 2003 | 161 | 0.020 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 2012 | 69 | 0.020 |
Why?
| Absorptiometry, Photon | 1 | 2013 | 248 | 0.020 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 331 | 0.020 |
Why?
| Models, Biological | 2 | 2010 | 1718 | 0.020 |
Why?
| Litter Size | 1 | 2011 | 16 | 0.020 |
Why?
| Software | 1 | 2016 | 607 | 0.020 |
Why?
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2010 | 15 | 0.020 |
Why?
| Biomechanical Phenomena | 2 | 2004 | 763 | 0.020 |
Why?
| Macrophages | 1 | 2018 | 1478 | 0.020 |
Why?
| Lower Extremity | 1 | 2014 | 403 | 0.020 |
Why?
| 3T3-L1 Cells | 1 | 2010 | 34 | 0.020 |
Why?
| Mice, Inbred BALB C | 1 | 2013 | 1243 | 0.020 |
Why?
| Active Transport, Cell Nucleus | 1 | 2010 | 113 | 0.020 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2010 | 132 | 0.020 |
Why?
| Risk Factors | 2 | 2016 | 9747 | 0.020 |
Why?
| Sex Factors | 1 | 2015 | 1961 | 0.020 |
Why?
| Lipoproteins | 1 | 2010 | 171 | 0.020 |
Why?
| Meiosis | 1 | 2009 | 63 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2021 | 7061 | 0.020 |
Why?
| Cluster Analysis | 1 | 2010 | 481 | 0.020 |
Why?
| Chromosomes | 1 | 2009 | 101 | 0.020 |
Why?
| Biomarkers | 1 | 2020 | 3968 | 0.020 |
Why?
| Bayes Theorem | 1 | 2010 | 375 | 0.020 |
Why?
| Cell Lineage | 1 | 2010 | 333 | 0.020 |
Why?
| Artificial Intelligence | 1 | 2010 | 245 | 0.020 |
Why?
| Retrospective Studies | 1 | 2024 | 14488 | 0.020 |
Why?
| Dissection | 1 | 2007 | 51 | 0.020 |
Why?
| Insulin-Like Growth Factor Binding Protein 4 | 1 | 2006 | 4 | 0.020 |
Why?
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2006 | 9 | 0.020 |
Why?
| Insulin-Like Growth Factor II | 1 | 2006 | 25 | 0.020 |
Why?
| Longitudinal Studies | 1 | 2014 | 2720 | 0.020 |
Why?
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2006 | 39 | 0.020 |
Why?
| Receptor, IGF Type 1 | 1 | 2006 | 65 | 0.020 |
Why?
| Microarray Analysis | 1 | 2006 | 122 | 0.020 |
Why?
| Genetic Linkage | 1 | 2007 | 299 | 0.020 |
Why?
| Infant, Newborn | 1 | 2018 | 5753 | 0.020 |
Why?
| Receptors, Somatotropin | 1 | 2005 | 8 | 0.020 |
Why?
| Cholesterol | 1 | 2007 | 411 | 0.010 |
Why?
| Sequence Alignment | 1 | 2005 | 331 | 0.010 |
Why?
| DNA Primers | 1 | 2006 | 510 | 0.010 |
Why?
| Triglycerides | 1 | 2007 | 527 | 0.010 |
Why?
| Drug Administration Schedule | 1 | 2006 | 767 | 0.010 |
Why?
| Stress, Mechanical | 1 | 2006 | 465 | 0.010 |
Why?
| Transfection | 1 | 2006 | 908 | 0.010 |
Why?
| Down-Regulation | 1 | 2006 | 636 | 0.010 |
Why?
| Brain | 1 | 2016 | 2664 | 0.010 |
Why?
| Alkaline Phosphatase | 1 | 2004 | 145 | 0.010 |
Why?
| Infant | 1 | 2018 | 9016 | 0.010 |
Why?
| Radiography | 1 | 2006 | 798 | 0.010 |
Why?
| Nitric Oxide Donors | 1 | 2003 | 19 | 0.010 |
Why?
| Guanylate Cyclase | 1 | 2003 | 33 | 0.010 |
Why?
| Nitroprusside | 1 | 2003 | 67 | 0.010 |
Why?
| Cyclic GMP | 1 | 2003 | 88 | 0.010 |
Why?
| Calcitriol | 1 | 2003 | 54 | 0.010 |
Why?
| Child, Preschool | 1 | 2018 | 10507 | 0.010 |
Why?
| Blotting, Western | 1 | 2006 | 1205 | 0.010 |
Why?
| Algorithms | 1 | 2010 | 1618 | 0.010 |
Why?
| Parathyroid Hormone | 1 | 2003 | 106 | 0.010 |
Why?
| Recombination, Genetic | 1 | 2003 | 190 | 0.010 |
Why?
| Phylogeny | 1 | 2006 | 849 | 0.010 |
Why?
| Human Growth Hormone | 1 | 2002 | 45 | 0.010 |
Why?
| Prospective Studies | 1 | 2014 | 7103 | 0.010 |
Why?
| Pregnancy | 1 | 2014 | 6384 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2006 | 1696 | 0.010 |
Why?
| Tibia | 1 | 2002 | 170 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 2003 | 826 | 0.010 |
Why?
| Recombinant Proteins | 1 | 2002 | 1303 | 0.010 |
Why?
| Kinetics | 1 | 2002 | 1641 | 0.010 |
Why?
| Adolescent | 1 | 2018 | 20378 | 0.010 |
Why?
| NF-kappa B | 1 | 2002 | 653 | 0.010 |
Why?
| Young Adult | 1 | 2014 | 12403 | 0.010 |
Why?
| Signal Transduction | 1 | 2006 | 4913 | 0.010 |
Why?
|
|
Ackert-Bicknell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|